Jesse Hinde is a research economist with more than a decade of experience conducting health economics and health policy research for federal and state agencies. Dr. Hinde’s research focuses on the economic implications of substance abuse and mental health disorders and policies that affect the demand for health insurance.
His current portfolio of work includes evaluations of CMS’ Section 1115 SUD demonstrations and State Innovation Model grants, a PCORI-funded study examining the benefits and challenges resulting from California's system-wide implementation of ASAM criteria, and the economic evaluation of an Effectiveness-Implementation Hybrid Trial brief intervention for substance use within community-based HIV/AIDS service organizations. Dr. Hinde is also the principal investigator of an AHRQ R03 grant examining the impacts the ACA’s advanced premium tax credits and cost-sharing subsidies.
Dr. Hinde has served as the project director for SAMHSA’s Pregnant and Postpartum Women (PPW) Pilot Evaluation, a multi-site, mixed methods evaluation of the residential and outpatient grant programs serving PPW with opioid use disorder. He was also the associate project director for the national cross-site evaluation of SAMHSA’s Screening, Brief Intervention, and Referral to Treatment (SBIRT) program, a comprehensive evaluation of the effects of system-wide SBIRT implementation and related health information technology initiatives on patient outcomes, provider practices, costs, program sustainability. In addition, Dr. Hinde recently led a study for ASPE on policy innovations in medication-assisted treatment financing and workforce development.